Amarin Corp PLC (AMRN) Options

Give the man his due , He is an expert on predicting the past

Great INformation ! Stock now in the 40's this is yet again another wonderful buying opportunity BUY BUY BUY . The charts show a double kangaroo houdin inversion coming I tell you what it means after it happens

Management never says a work. Nobody has any idea what is going on so it does not matter if they have 300 million in cash.

Well Rosem...... I figured over and above helping to find waste, fraud, and abuse in the government, there would be benefits to TESLA when it comes to getting regulatory approval for Full Self Driving and Optimus robots..... we'll see. In the mean time, I sure hope we start getting upside surprises tomorrow and get this AMRN investment out of the toilet.

North is there a problem opening the link? on left side, it shows a link for "all documents"
Below is link the grant of one patent.
https://register.epo.org/application?documentId=M5VLYMREQQFGE5M&number=EP24152359&lng=en&npl=false

I agree, sleven. New patents, new generics with unknown compositions in capsules, and new patent infringement suits filed against new and old generics where appropriate. Nothing absurd about that--even generics are aware in Delaware and New Jersey in current litigation.

Save everyone some time, lizzy, and print text of application or patent claims shown in respective claims. I'll return later tonight to view those claims.

fear of the unknown may have driven some sellers

BBI, this is pretty much what Denner has done since he took over - or at least for the past 18 months. Stop virtually all communication and leave everyone wondering. It has all been planned.

He has raised HUGE cash in the past 24 months ($600M+). His filings currently show only $290M in total investments. That's down $700M from the peak just a few years ago. Something big is going down.

Sleven, not sure I follow. If one or some of the generics stop selling IPE, then the others will naturally pick up that slack. PBM's will get their supply somewhere. I don't see what's absurd about that.

As to the tariffs, we don't quite know how that's going to impact each generic yet.

Ram, congrats on your good timing.  You got the calvalry coming in last night:

<a href="

FlyFishingStocks

Since Tesla also went down close to 25% Inc after hours are they going to 0 ? Many days after you said we would follow the market down but did not where were you then ? Seems you post only when the market fits your predictions IMO

Michael

BBI, With you all the way here'. Where we are (in value) - we just have to trust/believe that Sarissa/Denner have a plan.

This is 'What They Do' - how Denner made his Business - Making turnarounds in the Market' - against experts expectations'.
------------------------------------------------

Truth is that Amarin and Vascepa/Vazkepa is even further out than Trump' - aiming to concur this Planet - so no reason to Give up Hope - Yet 🙂

Volume interaction with overhead resistance has governed price direction.

Last week I shared this chart showing double top patterns where feeble up volume (B) led to a sharp sell off on heavy volume.


The volume reliably forecasted today's outcome

Todays chart:

I do recall the report three years ago when Amarin lost $50 million or $70 million in a quarter and it seemed that the share price was falling nonstop for two months before earnings were announced so it was clear that word had spread. This quarter, we've seen the opposite, where the stock has risen more days than not since the start of the year and volume has remained muted. I think if there was particularly bad news coming out, the company might have preannounced. Same if there was good news. Still, I guess it's possible that we lost $20 million in the Fourth Quarter. Hope not, but it's possible. And that might explain why there has been no rush to start a share buyback. Or maybe they're preparing to announce a way to get the share price over $1 that won't make investors happy. Besides the market's collapse today, fear of the unknown may have driven some sellers.

JRroon , I wasn't asking a question your response was absurd.
Sleven,

proliberty, could be margin calls not for AMRN but other stocks. KIM For every seller there's a buyer.

As TA forecasted, the .43 cent target was reached on the downside based on this chart I posted 1 week ago



The stock printed a new low today of .40. Wow... that is a -25% plunge intra-day.

Agreed. And in a typical company dominated by management and a captured BOD, you might well see enrichment of insiders at expense of shareholders / a full burn of any cash. In this case, Sarissa is in full control and should be able to force further cost cuts and a sale if the best option to avoid massive cash burn.

No question that it seems ridiculous. However, market is forward looking. It must think that revenue from the EU will not come fast enough to make up for losses here. Only thing I can think of that the market thinks that cash will evaporate in the future. Important to have an earnings report and CC that instills confidence that that won't happen.

I should add, that the market is sometimes pretty stupid. Huge valuations for companies that aren't making any money and many examples of stocks bashed to hell and lo and behold they resurrect.

Hayward, it is crazy. $193m market cap with $300m cash. They could just shut down, sell inventory and IP, and hand back something like $1.00-1.50 (assuming the patent does not have a negative value).

ProLiberty

From .53 to .40 on less then 3 million shares traded is crazy What happens when we trade 20 million in a day 0 ??

Michael

Thanks for these links, Lizzy. I'm still bullish on the new formulation...even if I'm not comfortable with what Denner is doing.

Bit of strange after market activity... someone put in a 98k share bid at $0.4884... got filled. Then 18k shares at same price... filled. Now 73k filled at $0.4652... another 27k at $0.4652. That was after getting beaten down with two or three 200k blocks and a 400k block during normal hours.

Are they selling a new drug we haven’t heard of? They can’t sell Vascepa anywhere.

They could fall much lower as you say but don't be fooled into just thinking of them as a car company........they are deep into AI and autonomous vehicles/robotics and energy......we'll see if my gamble pays off......

ziploc, please see my post above re LR-EtEPA patents.

https://register.epo.org/application?number=EP24152359&lng=en&tab=doclist

No question. As much as I bitch from time to time of how management did not do its fiduciary duty, I am the most guilty party. That was the time to sell for sure.

Agree with the first part. Definitely don’t agree with the lottery ticket part. Amarin has a history of repeating itself and it will again. The stock is due for a launch to where is the question.

For those who follow patent activity, see below 5/23/24 US20240165066A1 EU 12/04/24 #EP2374613A
https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2023146984
FDC status EP4338805 EP4342546
https://register.epo.org/application?number=EP24152348&tab=main

Holding after label approval was the opposite of what we all should have done. Could have sold for profit and never thought about this shitco again. But alas, I can’t sell and now holding onto a lottery ticket that very likely never hits.

Not to mention that growth could actually slow. Half the population (typical buyers) now shunning the brand and the other half of the population prefers petroleum based locomotion.

I've been adding shares of TSLA....... once the Musk Derangement Syndrome therapies kick in, the stock will head north.
They have a PE over 100 with growth stalled in an industry with a PE under 15%.

TSLA could very realistically fall to under $40.

Seems more typical for this to run up a week before quarterly report, then crash after the report. Looks like a different scenario at the moment

Just the last bit of braindead retail getting out before the turnaround here. Always a few that will do the opposite of what they should. This is the last great buy opportunity IMO. Save this post!

I've noticed that as well with my bios. If AMRN turns around today, I'm up nicely overall on a day when the market is getting killed. Hoping this signals a turnaround in the depression that has hit small pharmaceuticals in particular over the past few years.

Jron the the short is over on stockwits showing his full blown TDS. Now he has taken to trashing Trump The dude is beyond comical.

I've been adding shares of TSLA....... once the Musk Derangement Syndrome therapies kick in, the stock will head north.

Yep. I have a couple of bios that are turning green on a huge red day. Of course a bunch of other stuff in the red.

Doesn't it seem like we time our quarterly results to be released in the middle of every market crash?

My ray of hope is that Denner, though he might lack some knowledge that would be more helpful in growing the company, may have superior skills and contacts at putting together a buyout in the next year or two that can benefit all of us. I found it encouraging that he got rid of his hand-picked guy to run the company and turned it back over to people who have run Amarin for a decade or more. I haven't given up on him at all, especially since he's steering the ship right now. I'm sure a lot of people were critical of JT when he was running the company, since he was an accountant. Maybe an accountant was just what we needed then. Perhaps his slickest move, which eliminated the prospect of bankruptcy, came when he raised over a half billion dollars six months before Judge Du gave the company a near-fatal blow.

Not sure what you're asking

JRoon, ?
Sleven,

Sleven, that's certainly possible. Of course, we don't know that. There's 7 generics selling IPE, each with their own economics. What would actually make things worse for us is if several of them stop selling IPE, and thus handing more market share to the ones that are left.

But let's hope that the tariffs can put some kind of dent in their margins.

Amarin to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on March 12, 2025

I am looking forward to some discussion of Lr Et EPA at the C.C.

North, Given that Alex Denner essentially sold
The Medicines Company to NVS, one would hope
his relationship with NVS is such that they would at
least listen to what he may propose, and would be
able to disclose to NVS the new formulation that
could be the game changer...Most especially if NVS
were to take the idea and run with it!

Different space but Indian Sun Pharma buying Checkpoint Therapeutics.   Not sure if it has anything to with tariffs.  Probably not as Checkpoint had some positive news on their cancer drug.  But they have been losing money every quarter - still pre-clinical co. 

https://finance.yahoo.com/news/top-india-drugmaker-sun-buy-034544292.html

JRoon, At the moment our patents aren't providing any protection. That's the point behind the lawsuit. The only reason that Amarin has been able to maintain market share, is by negotiating better pricing with providers. The fact that they have been fairly successful is important. It tells us that our generic competition can't easily drop their wholesale prices below ours. If the generic companies are suddenly faced with a 10-20 percent increase in production cost, it will put them at a disadvantage.
Sleven,

1. Because they own the patent for CVD

2. Pricing flexibility

Well Rose, at the time we had just published the results of a 5 year landmark study that showed if you stack V on top of the #1 drug in the world (Statins not Viagra), you reduce the incidence of the #1 cause of death in the world. So it's hard to gauge whether the asking price was unrealistic. We had the whole market to ourselves until we lost it in the US to the corrupt system we have....... but all is not lost just yet....we have the EU until at least 2039 and a BP could definitely scale this thing by acquiring AMRN and then Doging the SG&A line...... with lower expenses and higher volume, you can reduce the price and it would then become just what JT envisioned....a volume play. Let's gettir done......